The Oncology Institute, Inc. (NASDAQ: TOI) reported Q2 EPS of ($0.19), $0.04 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $80.2 million versus the consensus estimate of $73.79 million.

GUIDANCE:

The Oncology Institute, Inc. sees FY2023 revenue of $290-320 million, versus the consensus of $304 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.